Lessons Learned from the European Cardiovascular Magnetic Resonance (EuroCMR) Registry Pilot Phase

被引:7
作者
Bruder O. [1 ]
Wagner A. [2 ]
Mahrholdt H. [3 ]
机构
[1] Department of Cardiology and Angiology, Elisabeth Hospital, 45138 Essen
[2] Hahnemann University Hospital, Drexel University College of Medicine, Philadelphia, PA
[3] Department of Cardiology, Robert Bosch Medical Centre, Stuttgart
关键词
Cardiovascular magnetic resonance; Effectiveness; Impact on patient management; Outcome; Quality; Registry; Safety;
D O I
10.1007/s12410-010-9016-x
中图分类号
学科分类号
摘要
The data from 11,040 patients of the European Cardiovascular Magnetic Resonance (EuroCMR) registry pilot phase offer the first documentation of the clinical use of CMR in a routine setting. The pilot data show that CMR is frequently performed in clinical practice, is a safe procedure with excellent image quality, and has a strong impact on patient management. In the future, the EuroCMR registry will help to set international benchmarks on appropriate indications, quality, and safety of CMR. In addition, outcome and cost effectiveness will be addressed on an international level in order to develop optimized imaging-guided clinical pathways and to avoid unnecessary or even harmful testing. © 2010 The Author(s).
引用
收藏
页码:171 / 174
页数:3
相关论文
共 23 条
  • [11] Bruder O., Schneider S., Nothnagel D., Et al., EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase, J Am Coll Cardiol, 54, pp. 1457-1466, (2009)
  • [12] Tops L.F., Delgado V., van der Kley F., Et al., Percutaneous aortic valve therapy: clinical experience and the role of multi-modality imaging, Heart, 95, pp. 1538-1546, (2009)
  • [13] Cheng A.S., Pegg T.J., Karamitsos T.D., Et al., Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla, J Am Coll Cardiol, 49, pp. 2440-2449, (2007)
  • [14] Dukkipati S.R., Mallozzi R., Schmidt E.J., Et al., Electroanatomic mapping of the left ventricle in a porcine model of chronic myocardial infarction with magnetic resonance-based catheter tracking, Circulation, 118, pp. 853-862, (2008)
  • [15] Hendel R.C., Patel M.R., Kramer C.M., Et al., ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic, J Am Coll Cardiol, 48, pp. 1475-1497, (2006)
  • [16] Schwitter J., Nanz D., Kneifel S., Et al., Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography, Circulation, 103, pp. 2230-2235, (2001)
  • [17] Schwitter J., Wacker C.M., van Rossum A.C., Et al., MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial, Eur Heart J, 29, pp. 480-489, (2008)
  • [18] McCrohon J.A., Moon J.C., Prasad S.K., Et al., Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation, 108, pp. 54-59, (2003)
  • [19] Mahrholdt H., Wagner A., Deluigi C.C., Et al., Presentation, patterns of myocardial damage, and clinical course of viral myocarditis, Circulation, 114, pp. 1581-1590, (2006)
  • [20] Jahnke C., Nagel E., Gebker R., Et al., Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging, Circulation, 115, pp. 1769-1776, (2007)